Marco A. S. Baptista

Author

Also Known As

Baptista, Marco, Baptista, Marco A. S., Lee, Jung-Jin, M. A. Baptista, M. Baptista, M.A.S Baptista, M.A.S. Baptista, Marco A.S. Baptista, Marco A. S. Baptista, Marco A.S Baptista

Publications

Citations

H-Index

101

Concepts

All Affiliations

Michael J. Fox Foundation University of Toronto Scripps Research Institute University of Dundee Columbia University

About

Marco A. S. Baptista is an author at Michael J. Fox Foundation specializing in medicine, neuroscience, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	2K
2	Health Sciences	4	4	76
3	Engineering	1	1	40
4	Natural Sciences	1	1	177
5	Public Health	1	1	36

Marco A. S. Baptista

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases Martin Steger, Francesca Tonelli, Genta Ito, eLife MitophagyMolecular BiologyRab GtpasesLrrk2 Kinase InhibitorsSignaling Pathway	2016	1K
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung Reina N. Fuji, Michael Flagella, Miriam Baca, Science Translational Medicine	2015	363
Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer Marco A. S. Baptista, Rémi Martin‐Fardon, Friedbert Weiss Journal of Neuroscience	2004	237
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth, Neurobiology of Disease	2014	225
Activation of Group II Metabotropic Glutamate Receptors Attenuates Both Stress and Cue-Induced Ethanol-Seeking and Modulates c-<i>fos</i>Expression in the Hippocampus and Amygdala Yu Zhao, Christopher V. Dayas, Harinder Aujla, Journal of Neuroscience NeuropsychologySynaptic TransmissionAffective NeurosciencePsychopharmacologyGroup Ii Mglurs	2006	195
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs Marco A. S. Baptista, Kuldip D. Dave, Mark Frasier, PLoS ONE	2013	183
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors Genta Ito, Kristina Katsemonova, Francesca Tonelli, Biochemical Journal Signal RecognitionMolecular BiologyPhos-tag AnalysisMajor Rab10 KinaseCell Regulation	2016	177
Pavlovian psychopharmacology: The associative basis of tolerance. Shepard Siegel, Marco A. S. Baptista, Joseph A. Kim, Experimental and Clinical Psychopharmacology PsychiatryBehavioral PharmacologyPavlovian PsychopharmacologyPsychopharmacologyPsychology	2000	146
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity Jack D. Scott, Duane E. DeMong, Thomas J. Greshock, Journal of Medicinal Chemistry Drug TargetPharmacotherapyMedicinal ChemistryBrain Kinase ActivityLrrk2 Inhibitors	2017	140
Both Nicotinic and Muscarinic Receptors in Ventral Tegmental Area Contribute to Brain-Stimulation Reward John Yeomans, Marco A. S. Baptista Pharmacology Biochemistry and Behavior Neurobiological MechanismBehavioral NeuroscienceNeuroanatomyNeurophysiologyPhysiology	1997	137

Page 1